jp morgan glp 1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article JP Morgan Targets Weight Loss
Description
3 Effects of GWAS index SNPs in the vicinity of GLP1R locus on efficacy and side effects, partitioned by drug type
![jp morgan glp 1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article JP Morgan Targets Weight Loss](https://athletechnews.com/wp-content/uploads/2024/06/shutterstock_editorial_1465185422-2.webp)
Therefore, compared to other GLP-1R agonists, exendin-phe1 possesses advantageous pharmacological properties that maximizes insulin secretion
![jp morgan glp 1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article JP Morgan Targets Weight Loss](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/WEGOVY.jpg?VersionId=dXyQQq.CTQDP5u.cwY3zM.t7ShaNtZUt)
El estrato crneo, la capa ms externa de la piel, normalmente impide la penetracin de molculas con peso molecular superior a 500 Daltons (regla de Potts & Guy), mientras que los agonistas GLP-1 varan considerablemente en tamao molecular: desde aproximadamente 3,000-4,000 Daltons para semaglutida y liraglutida, hasta cerca de 59,000 Daltons para dulaglutida
![jp morgan glp 1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article JP Morgan Targets Weight Loss](https://www.statnews.com/wp-content/uploads/2024/09/AdobeStock_831183966-645x645.jpeg)
Tirzepatide works as a dual agonist, activating both GLP-1 and GIP receptors simultaneously
![jp morgan glp 1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article JP Morgan Targets Weight Loss](https://static.wixstatic.com/media/0b4214_b836df00a9924b7ca3088860246bf924~mv2.jpg/v1/fill/w_568,h_378,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/0b4214_b836df00a9924b7ca3088860246bf924~mv2.jpg)
While bariatric surgery will remain an important option, a newer, more powerful GLP-1 will give patients with very high BMIs something important: a choice.
Understanding your unique genetic profile helps predict which GLP-1 compound and approachinjection or oralwill optimize your weight loss and metabolic outcomes